BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu WT, Liu WB, Gao M, Zhang YY, Gu KS. Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer. Oncol Lett 2019;18:4573-82. [PMID: 31611965 DOI: 10.3892/ol.2019.10798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Razmi M, Ghods R, Vafaei S, Sahlolbei M, Saeednejad Zanjani L, Madjd Z. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis. Cancer Cell Int 2021;21:139. [PMID: 33639931 DOI: 10.1186/s12935-021-01840-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Aramini B, Masciale V, Bianchi D, Manfredini B, Banchelli F, D'Amico R, Bertolini F, Dominici M, Morandi U, Maiorana A. ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? Front Med (Lausanne) 2020;7:544158. [PMID: 33195295 DOI: 10.3389/fmed.2020.544158] [Reference Citation Analysis]
3 Zhang M, Liu Y, Kong D. Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma. J Bone Oncol 2021;26:100331. [PMID: 33376666 DOI: 10.1016/j.jbo.2020.100331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Xiang Z, He Q, Huang L, Xiong B, Xiang Q. Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation. Front Oncol 2021;11:818869. [PMID: 35083162 DOI: 10.3389/fonc.2021.818869] [Reference Citation Analysis]
5 Han Y, Sun B, Cai H, Xuan Y. Simultaneously target of normal and stem cells-like gastric cancer cells via cisplatin and anti-CD133 CAR-T combination therapy. Cancer Immunol Immunother 2021;70:2795-803. [PMID: 33635343 DOI: 10.1007/s00262-021-02891-x] [Reference Citation Analysis]
6 Kim J, Shin K, Lee SH, Kim IH. Slug and CD133 expression are associated with peritoneal carcinomatosis and survival in gastric cancer. J Gastrointest Oncol 2021;12:1326-37. [PMID: 34532091 DOI: 10.21037/jgo-21-123] [Reference Citation Analysis]
7 Rezaee M, Gheytanchi E, Madjd Z, Mehrazma M. Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma. Iran J Pathol 2021;16:40-50. [PMID: 33391379 DOI: 10.30699/ijp.2020.127441.2389] [Reference Citation Analysis]
8 Mazzio E, Badisa R, Mack N, Cassim S, Zdralevic M, Pouyssegur J, Soliman KFA. Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase. Cancer Genomics Proteomics 2020;17:469-97. [PMID: 32859627 DOI: 10.21873/cgp.20205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism. Front Oncol 2022;12:918778. [DOI: 10.3389/fonc.2022.918778] [Reference Citation Analysis]